Performa HargaHarga kembali 1 minggu-
Harga kembali 1 Bulan-
Harga kembali 3 Bulan-
Harga kembali 6 Bulan-
Harga Tertinggi (52 Minggu)6.92
Harga Terendah (52 Minggu)3.18
Latar Belakang Perusahaan
Iovance Biotherapeutics berfokus pada pengembangan terapi imunoterapi berbasis sel untuk mengobati kanker.
Summary
Valuation Information
Current PE Ratio (TTM)-9.26
Forward PE Ratio-
Current Price to Book Value3.87
Current Price to Sales8.06
EV to Revenue8.63
EV to EBITDA-8.68
PEG Ratio-
Per Share
Current EPS (Annualized)-0.69
Diluted EPS (TTM)-0.69
Revenue Per Share0.79
Current Book Value Per Share1.64
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-259603008
Profit Margin-0.891
Operating Margin-0.523
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
